Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
138.00    -7.00 (-4.83%)
Bid:
138.00
Ask:
144.50
Spread: 6.50 (4.71%)
Market Cap: £108.29m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Trading Statement

17 Jul 2014 07:00

RNS Number : 5362M
Xaar PLC
17 July 2014
 



17 July 2014

 

Xaar plc

 

Trading Statement

Xaar plc ("Xaar", "the Group" or "the Company"), the digital inkjet printing technology Group headquartered in Cambridge, UK, announces an update on trading.

 

Trading remains in line with the Board's expectations. Xaar expects to report revenue for the first half of 2014 of £60 million (H1 2013 - £67.2 million). As reported previously given normal seasonal patterns the Board expects a higher level of sales in the second half of the year, with full year revenue of approximately £130 million projected for 2014.

The Group continues to maintain a strong balance sheet with net cash at 30 June 2014 of £48.1 million (31 December 2013 - £53.5 million). As expected, cash balances reduced during the first half of the year due to investment in manufacturing and development assets, increased working capital and dividend payments.

The Company expects to announce Interim Results for 2014 on 28 August 2014.

 

 

Contacts

 

Xaar plc

Ian Dinwoodie, Chief Executive Officer

01223-423663

Alex Bevis, Finance Director

www.xaar.com

Tulchan Communications

Tom Buchanan

020-7353-4200

Christian Cowley

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEQLFFZDFXBBK
Date   Source Headline
30th Nov 20123:32 pmRNSTotal Voting Rights
22nd Oct 20127:00 amRNSDirector/PDMR Shareholding
18th Oct 20127:00 amRNSIMS and Corporate Open Day
1st Oct 20122:58 pmRNSTotal Voting Rights
26th Sep 20127:00 amRNSTR-1
24th Sep 20127:00 amRNSXAAR'S PARTNERS LAUNCH XAAR 1001 GS12 PRINTERS
3rd Sep 20123:19 pmRNSTotal Voting Rights
16th Aug 20127:00 amRNSInterim Results
1st Aug 201210:02 amRNSTotal Voting Rights
24th Jul 20127:00 amRNSXaar Joins Make It In Great Britain Exhibition
19th Jul 20127:00 amRNSTrading Statement
18th Jul 20129:34 amRNSHolding(s) in Company
13th Jul 20124:41 pmRNSHolding(s) in Company
3rd Jul 20124:23 pmRNSAdditional Listing
29th Jun 20126:20 pmRNSBlocklisting Interim Review
28th Jun 20127:00 amRNSPositive Response To New P3 Product Launch
27th Jun 201210:04 amRNSHolding(s) in Company
26th Jun 201210:11 amRNSDirector/PDMR Shareholding
12th Jun 20125:39 pmRNSHolding(s) in Company
11th Jun 20124:31 pmRNSDirector/PDMR Shareholding
7th Jun 201210:10 amRNSHolding(s) in Company
1st Jun 20129:24 amRNSDirector Declaration
31st May 20124:54 pmRNSTotal Voting Rights
22nd May 20124:54 pmRNSResult of AGM
17th May 20121:21 pmRNSHolding(s) in Company
4th May 20127:00 amRNSNotice of AGM
3rd May 20124:35 pmRNSHolding(s) in Company
2nd May 20123:12 pmRNSGrant of Options
1st May 20129:38 amRNSTotal Voting Rights
25th Apr 20125:21 pmRNSHolding(s) in Company
25th Apr 201211:26 amRNSDirector/ PDMR Shareholding
23rd Apr 20127:00 amRNSDirector/PDMR Shareholding
19th Apr 20127:00 amRNSAnnual Information Update
19th Apr 20127:00 amRNSInterim Management Statement
16th Apr 20126:13 pmRNSDirector/PDMR Shareholding - Replacement
13th Apr 20128:54 amRNSDirector/PDMR Shareholding
5th Apr 20123:25 pmRNSDirector/PDMR Shareholding
3rd Apr 20127:00 amRNSIssue of Options
30th Mar 20125:39 pmRNSTotal Voting Rights
19th Mar 20127:00 amRNSFinal Results
15th Mar 20127:00 amRNSHolding(s) in Company
9th Mar 20124:00 pmRNSHolding(s) in Company
1st Mar 20128:30 amRNSHolding(s) in Company
29th Feb 20128:48 amRNSHolding(s) in Company
28th Feb 20127:00 amRNSChange of 2011 Results Announcement Date
20th Feb 20125:33 pmRNSHolding(s) in Company
20th Feb 20125:24 pmRNSHolding(s) in Company
24th Jan 20126:05 pmRNSHolding(s) in Company
24th Jan 20127:00 amRNSChina Staff Changes
19th Jan 20127:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.